Home›Companies›Healthcare›Xenocor

Xenocor, Inc.

Updated Oct 27, 2026·Latest SEC filing Mar 21, 2023·Suggest an edit

About Xenocor

Xenocor is a private company based in Salt Lake City, Utah, incorporated in 2022 in Utah. It has reported $4,957,167 raised in one offering on Form D since March 2023. Its chief executive is Charles Decoster IV.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 5, 2021Mar 21, 2023$4,957,167of $10.0M target89$55,699EquityRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Xenocor's Form D filed Mar 21, 2023.

SF
Shawn Fojtik
Director
GB
George Baran
Director
MF
Mark Foster
Director
JH
Jim Hogan
Director
AW
CI
Charles Decoster IV
Chief Executive Officer and director
DP
Dinesh Patel
Director

Sources

  1. SECXenocor, Inc. filing history